A number of firms have modified their ratings and price targets on shares of Smith & Nephew plc (LON: SN) recently:

  • 7/31/2017 – Smith & Nephew plc had its price target raised by analysts at J P Morgan Chase & Co from GBX 1,280 ($16.67) to GBX 1,361 ($17.72). They now have a “neutral” rating on the stock.
  • 7/28/2017 – Smith & Nephew plc had its “neutral” rating reaffirmed by analysts at Credit Suisse Group. They now have a GBX 1,280 ($16.67) price target on the stock.
  • 7/28/2017 – Smith & Nephew plc had its price target raised by analysts at Jefferies Group LLC from GBX 1,350 ($17.58) to GBX 1,515 ($19.73). They now have a “buy” rating on the stock.
  • 7/28/2017 – Smith & Nephew plc had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a GBX 1,200 ($15.63) price target on the stock.
  • 7/25/2017 – Smith & Nephew plc had its “neutral” rating reaffirmed by analysts at J P Morgan Chase & Co. They now have a GBX 1,280 ($16.67) price target on the stock.
  • 7/20/2017 – Smith & Nephew plc had its “neutral” rating reaffirmed by analysts at Credit Suisse Group. They now have a GBX 1,200 ($15.63) price target on the stock.
  • 7/18/2017 – Smith & Nephew plc had its “hold” rating reaffirmed by analysts at Berenberg Bank. They now have a GBX 1,300 ($16.93) price target on the stock.
  • 7/17/2017 – Smith & Nephew plc had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a GBX 1,200 ($15.63) price target on the stock.
  • 7/10/2017 – Smith & Nephew plc had its “hold” rating reaffirmed by analysts at HSBC Holdings plc. They now have a GBX 1,320 ($17.19) price target on the stock.
  • 7/10/2017 – Smith & Nephew plc had its “sell” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 1,160 ($15.11) price target on the stock.
  • 6/30/2017 – Smith & Nephew plc had its “neutral” rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The). They now have a GBX 1,380 ($17.97) price target on the stock.
  • 6/22/2017 – Smith & Nephew plc had its “sell” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 1,160 ($15.11) price target on the stock.

Smith & Nephew plc (SN) opened at 1331.00 on Friday. The firm’s 50-day moving average price is GBX 1,328.35 and its 200 day moving average price is GBX 1,278.68. The stock’s market cap is GBX 11.66 billion. Smith & Nephew plc has a 52-week low of GBX 1,064.91 and a 52-week high of GBX 1,387.89.

The company also recently announced a dividend, which will be paid on Wednesday, November 1st. Shareholders of record on Thursday, October 5th will be paid a dividend of $0.12 per share. This represents a yield of 0.72%. The ex-dividend date of this dividend is Thursday, October 5th.

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with Analyst Ratings Network's FREE daily email newsletter.